Cargando…
Protein kinase D1 regulates ERα-positive breast cancer cell growth response to 17β-estradiol and contributes to poor prognosis in patients
About 70% of human breast cancers express and are dependent for growth on estrogen receptor α (ERα), and therefore are sensitive to antiestrogen therapies. However, progression to an advanced, more aggressive phenotype is associated with acquisition of resistance to antiestrogens and/or invasive pot...
Autores principales: | Karam, Manale, Bièche, Ivan, Legay, Christine, Vacher, Sophie, Auclair, Christian, Ricort, Jean-Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302658/ https://www.ncbi.nlm.nih.gov/pubmed/25287328 http://dx.doi.org/10.1111/jcmm.12322 |
Ejemplares similares
-
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018) -
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015) -
Sphingosine-1-Phosphate as Lung and Cardiac Vasculature Protecting Agent in SARS-CoV-2 Infection
por: Karam, Manale, et al.
Publicado: (2023) -
Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation
por: Totta, Pierangela, et al.
Publicado: (2016) -
Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
por: Mondal, Samim Ali, et al.
Publicado: (2023)